PDCD1 and neoplasm: This presented an opportunity to investigate the in vitro efficacy of a PD-1/PD-L1 axis inhibitor in PBMC/CRC cocultures as we hypothesised that addition of a checkpoint inhibitor would increase lymphocyte-related tumour cell death by overcoming any inhibitory effect of PD-L1 upregulation.